ArticleOncoTargets and therapy2025

Redefining Therapeutic Boundaries: PD-1 Blockade Facilitates Surgical Cure in EGFR-TKI Refractory EGFR-Mutant NSCLC with Pleural Metastases.

Yong-Liang Niu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.